Minireviews
Copyright ©The Author(s) 2023.
World J Clin Cases. Jan 16, 2023; 11(2): 299-307
Published online Jan 16, 2023. doi: 10.12998/wjcc.v11.i2.299
Table 1 Timeline for monitoring trans men
Laboratory evaluation
Baseline blood testsTestosterone, estradiol; CBC (including Hct or Hgb); Liver enzymes, lipid profile, creatinine; Fasting glucose (and HbA1c or oral glucose tolerance test if diabetes is suspected)
4-6 wk after starting treatmentTestosterone, estradiol; CBC (including Hct or Hgb)
3, 6, 9, and 12 mo after starting treatmentTestosterone, estradiol; CBC (including Hct or Hgb); Liver enzymes, lipid profile, creatinine (every 6 mo); Fasting glucose (every 6 mo)
Semiannually or annually thereafterTestosterone, estradiol; CBC (including Hct or Hgb); Liver enzymes, lipid profile, creatinineFasting glucose (every 6 mo)
In 50 yr of age (only if treatment is stopped or when risk factors for osteoporosis exist) and accordingly thereafterBone mineral density measurement
Individualized approachScreening tests for breast and endometrial cancer (with no prior hysterectomy)
Clinical assessment
Regular clinical examination (including body weight and blood pressure measurements), evaluation of masculinization, recording and monitoring of potential side effects
Table 2 Timeline for monitoring trans women
Laboratory evaluation
Baseline blood testsTestosterone, estradiol; Prolactin; CBC; Liver enzymes, lipid profile, creatinine; Fasting glucose (and HbA1c or oral glucose tolerance test if diabetes is suspected); Electrolytes; Coagulation tests (in case of high risk for thrombosis)
1 mo after starting treatmentCBC; Liver enzymes, lipid profile, creatinine; Electrolytes (if taking spironolactone)
3, 6, 9, and 12 mo after starting treatmentTestosterone, estradiol; CBC; Liver enzymes, lipid profile, creatinine (every 6 mo); Fasting glucose (every 6 mo); Electrolytes (if taking spironolactone)
Semiannually or annually thereafterTestosterone, estradiol; Prolactin (every 2 yr); CBC; Liver enzymes, lipid profile, creatinine; Fasting glucose (every 6 mo); Electrolytes (if taking spironolactone)
In 60 yr of age (or earlier if treatment is stopped after orchiectomy or when risk factors for osteoporosis exist) and accordingly thereafterBone mineral density measurement
Individualized approachScreening tests for prostate and breast cancer
Clinical assessment
Regular clinical examination (including body weight and blood pressure measurements), evaluation of feminization, recording and monitoring of potential side effects